NCT03992664 2025-02-13
Education Intervention in Patients with Rash Due to Epidermal Growth Factor Receptor (EGFR) Treatment.
Cyprus University of Technology
Phase NA Completed
Clinical Trials
15 trialsNCT06688643 2024-11-14
The Impact of Intrathecal Morphine Versus Continuous Epidural Analgesia on Return of Bowel Function in Patients Undergoing Laparoscopic Ileal Conduit
Inner Mongolia Baogang Hospital
Phase NA Completed
NCT04018209 2024-11-01
PANAM
University Hospital, Brest
Completed
NCT03721172 2024-05-29
ADVANCE
Amgen
Phase 3 Completed
NCT03673878 2022-01-27
PRURI-C
University Hospital, Brest
Completed
NCT02646020 2021-05-18
EGFR-TKIs
Sun Yat-sen University
Phase 2 Completed
NCT03796052 2020-11-04
Study Determining Safety and Efficacy of Avena Sativa (Oat) Skincare Products for Treating Skin Dryness and Itching in Cancer Patients
Johnson & Johnson Consumer and Personal Products Worldwide
Phase NA Completed
NCT00814073 2019-12-03
AB06006
AB Science
Phase 3 Completed
NCT01815424 2019-04-16
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Asian Subjects With Moderate To Severe Plaque Psoriasis
Pfizer
Phase 3 Completed
NCT01186744 2018-12-26
A Study To Evaluate The Effects And Safety Of Treatment, Treatment Withdrawal, Followed By Re-Treatment With CP-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Pfizer
Phase 3 Completed
NCT01241591 2018-12-26
A Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Comparing CP- 690,550 And Etanercept In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Pfizer
Phase 3 Completed
NCT03290989 2017-09-25
PRURITCC
University Hospital, Brest
Completed
NCT01831466 2015-11-25
Tofacitinib Ointment For Chronic Plaque Psoriasis
Pfizer
Phase 2 Completed
NCT01276639 2014-09-19
A One-Year Study To Evaluate The Effects And Safety Of CP-690,550 In Patients With Moderate To Severe Chronic Plaque Psoriasis
Pfizer
Phase 3 Completed
NCT01309737 2014-09-19
A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Pfizer
Phase 3 Completed